HolderBook

LANDOS BIOPHARMA INC (LABP)

Institutional ownership reported to the SEC as of Q1 2024, across 14 quarters.

13
Reporting holders
$34.2M
Reported value
0.0%
Held as options
+5
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
PERCEPTIVE ADVISORS LLC$31.9M1,486,9910.56%4qHELD
DELTEC ASSET MANAGEMENT LLC$1.1M50,0000.21%newNEW
MACQUARIE GROUP LTD$316.0K14,7180.00%3qHELD
GEODE CAPITAL MANAGEMENT, LLC$271.0K12,6040.00%3qHELD
PenderFund Capital Management Ltd.$270.8K9,3000.07%newNEW
Black Maple Capital Management LP$223.5K10,4050.14%newNEW
UBS Group AG$87.7K4,0840.00%4q+9623.8%+$86.8K
Tower Research Capital LLC (TRC)$19.2K8960.00%newNEW
JPMORGAN CHASE & CO$2.5K1180.00%4qHELD
Royal Bank of Canada$1.0K610.00%newNEW
MORGAN STANLEY$837390.00%newNEW
RENAISSANCE TECHNOLOGIES LLC$40618,8900.00%3q+67.8%
Virtu Financial LLC$31314,5370.02%newNEW
Cornerstone Planning Group LLC$267120.00%2qHELD
WELLS FARGO & COMPANY/MN$215100.00%4qHELD
ACADIAN ASSET MANAGEMENT LLC$21340.00%newNEW

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q1 202413$34.2M1,589,2386100.0%
Q4 20238$5.5M1,514,5371300.0%
Q3 20239$5.9M1,516,8492110.0%
Q2 20237$6.3M1,489,2927000.0%
Q1 202315$4.6M15,433,8513350.0%
Q4 202216$7.7M15,456,9025140.0%
Q3 202226$14.0M21,601,3804490.0%
Q2 202232$16.4M22,465,56686130.0%
Q1 202243$35.3M23,904,238811120.0%
Q4 202139$191.1M39,818,82091170.0%
Q3 202135$331.1M22,674,75069140.0%
Q2 202132$433.2M37,583,62201280.0%
Q1 202147$218.9M23,255,20446000.0%
Q4 20201$1.0K1001000.0%